Resources
The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Filter by:
Topic
Topic
- (-) Accountable Care Organizations
- Alternative Payment Models
- Biopharmaceutical Innovation
- Bundled Payments
- Clinical Pathways
- (-) Decision Frameworks
- (-) Elements of Value
- Evidence for Decision Making
- (-) Formulary/Benefit Design
- Formulary Development
- Good Practices for Evidence
- Health Care Quality Measures
- Health Spending
- Health Spend Management
- High-Deductible Health Plans
- Impact on Outcome & Spending
- Individual Treatment Effects & Personalized Access
- IRA Implementation
- Low-Value Care
- Pandemic Response
- Patient Cost Sharing
- Paying for Cures
- Policy & Regulatory Barriers
- Real-World Data
- Real-World Evidence
- Regulatory Barriers & Challenges
- (-) Understanding Health Spending
- Utilization Management & Step Therapy
- Value-Based Contracts
- Value-Based Insurance Design
- Value Assessment
- Value Assessment Frameworks
- Value Assessment Methods
Resource Type
Display Only
Showing 137 Results
NPC in AJPB: Working Toward Better Value in Prescription Drug Benefits Management
U.S. employers provide a vital link to health care, with more than 56 percent of them offering health insurance for their employees. However, how employers design those health benefits can vary…
Toward Better Value
There is a disconnect between the important role employers believe their pharmacy benefit managers (PBMs) play in helping to manage prescription drug benefits and employers’ perceptions of the…
NPC Talks Value, Benefit Design at AMCP Research Symposium and Nexus 2017
The National Pharmaceutical Council (NPC) is pleased to be participating in next week’s Academy of Managed Care Pharmacy (AMCP) Nexus 2017 meeting in Dallas, Texas. As a sponsor of and participant in…
NPC in Chain Drug Review: Should Patients With the Same Condition Bear Different Costs?
NPC President Dan Leonard tackles variable copays in his latest commentary for Chain Drug Review. In it, he considers when variable cost-sharing is less acceptable for patients who require higher…
Checking In With Schaeffer-NPC Postdoctoral Fellow in Health Policy, Dr. Ilene Hollin
Ilene Hollin, PhD, is entering the second year of her NPC-USC Schaeffer Center Health Policy fellowship, a post-doctoral, two-year fellowship that seeks to bridge the gap between health research and…
Same Condition, Different Costs: Should Patients Pay Different Amounts?
Patients who have the same condition sometimes pay different out-of-pocket costs for their medications, but when is this differential more appropriate? Join NPC in tackling this dilemma in the…
NPC @ AcademyHealth Annual Research Meeting: What Do We Know about High-Deductible Health Plans?
NCP Health Policy Fellow Ilene L. Hollin, PhD, MPH, will moderate a panel, “What Do We Know about High-Deductible Health Plans and What Do We Need to Learn?” to discuss what we know – and don’t know …
Optimization of Medication Use at Accountable Care Organizations
This study assesses a broad range of factors related to how accountable care organizations optimize medication use and meet financial and quality metrics.
Incorporating What Matters to Patients in Quality Measures: A Discussion With NPAF’s Dr. Balch
NPC spoke with Alan Balch, PhD, chief executive officer of the National Patient Advocate Foundation, to ask his thoughts about the impact of quality measures on patient care, particularly in the…
How Can We Improve Oncology Quality Measurement in Accountable Care?
NPC and Discern Health analyzed the current oncology quality measure landscape for 10 high-priority cancers, published in the white paper "Improving Oncology Quality Measurement in Accountable Care,"…
When Is It Less Acceptable for Patients to Face Higher Cost-Sharing?
A new study explores when variation in consumer cost-sharing makes sense, and when it is less acceptable for patients with the same or similar conditions to have different out-of-pocket costs, as…
Does a One Size Fits All Cost-Sharing Approach Incentivize Appropriate Medication Use?
Patients contribute to health care costs through out-of-pocket expenses, like copays and coinsurance. These cost-sharing mechanisms are intended to help payers manage costs and…
Does a One-Size-Fits-All Cost-Sharing Approach Incentivize Appropriate Medication Use? A Roundtable on the Fairness and Ethics Associated with Variable Cost Sharing
A study convened an expert roundtable of patient, payer, and employer representatives to review four case studies to understand when it would be more (or less) acceptable to require patients…
Missed Signals in Cancer Care: Strategies to Address Quality Measure Gaps
When it comes to designing accountable care models, the dramatically varied needs and preferences of patients with cancer can confound quality measurement, especially when compounded by increasingly…
Improving Oncology Quality Measurement in Accountable Care: Filling Gaps with Cross-Cutting Measures
According to a study, gaps in the quality measures used by accountable care programs to assess cancer care may obscure problems in care delivery and lead to missed opportunities for improvement of…
Pharmacy Benefits: Super-sized, Minimized or Right-Sized?
In the December issue of Employee Benefit News, NPC Vice President of Comparative Effectiveness Research Jennifer Graff, PharmD, outlines a framework for the consideration of treatment flexibility in…